Arkansas rates for HCPCS M0241

Intravenous Infusion Or Subcutaneous Injection Casirivimab And Imdevimab Includes Infusion Or Injection And Post Administration Monitoring In The Home Or Residence This Includes A Beneficiarys Home That Has Been Made Provider-Based To The Hospital During The Covid-19 Public Health Emergency Subsequent Repeat Doses